Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: Spain Clear all

198 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20061
20072
20082
20095
20108
20112
20124
20135
20145
20156
201616
201715
201814
201924
202015
202121
202212
20232
202413
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Terminated46
Recruiting30
Active, not recruiting26
Unknown status5
Not yet recruiting3
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PETHEMA Foundation21
Novartis Pharmaceuticals15
AbbVie11
Celgene10
Janssen Research & Development, LLC10
Astellas Pharma Global Development, Inc.5
Daiichi Sankyo5
Institut de Recherches Internationales Servier5
Stichting Hemato-Oncologie voor Volwassenen Nederland5
Taiho Oncology, Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute198
Myelodysplastic Syndromes42
Leukemia28
Recurrence25
Precursor Cell Lymphoblastic Leukemia-Lymphoma20
Leukemia, Myelomonocytic, Chronic18
Neoplasms16
Multiple Myeloma15
Hematologic Neoplasms13
Lymphoma, Non-Hodgkin12

Trials

Showing 1 to 25 of 198. Each trial links to its page on Pharma Observatory.

98 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.